|
Nutraplus Products (India) Limited was originally incorporated as a private limited company on 6 Feb.'90. It was subsequently converted into a public limited company with effect from 13 Jun.'92. The company implemented a project for the manufacture of veterinary bulk drugs namely dimentridazole (DMZ) and dinitolmide (DOT) at Tarapur Maharashtra. Initially the company set up manufacturing facilities for the manufacture of methyl nitro imidazole an intermediate of DMZ with an installed capacity of 240 tpa at a cost of Rs 123.66 lac for which was sanctioned a term loan of Rs 60 lac from the Maharashtra State Financial Corporation (MSFC).The company has set-up new product Roxarsone from Jan'96 and also set up production of Dinitolmide. During 2001-02 the company set up a production of newly developed Bulk Drugs Metformin HCL. It is also planning to foray in the manufacture of life saving drugs. |
Nutraplus India Ltd.
| BSE: 524764 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE230G01020 |
| BSE 00:00 | 13 Dec | Nutraplus India Ltd |
| NSE 05:30 | 01 Jan | Nutraplus India Ltd |
| OPEN | 1.90 |
| PREVIOUS CLOSE | 2.10 |
| VOLUME | 43184 |
| 52-Week high | 2.17 |
| 52-Week low | 1.82 |
| P/E | |
| Mkt Cap.(Rs cr) | 7 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Nutraplus India Ltd. (NUTRAPLUSINDIA) - Company History
Quick Links for Nutraplus India:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
